Ophthalmology

OphthalmologyAugust 2025Letter

Re: Vasu et al.: Risk of glaucoma in patients without diabetes using a glucagon-like peptide 1 receptor agonist (Ophthalmology. 2025;132:859-868).

Authors

Zuhair Zaidi, Ahmed Alshaikhsalama, Amer Alsoudi, Ehsan Rahimy

No abstract available for this article.

More by Zuhair Zaidi

View full profile →

Risk of diabetic retinopathy progression after YAG laser capsulotomy.

2026J Cataract Refract Surg

In the Knowledge Library

Clinical Epidemiology of GlaucomaSystemic Medications And Glaucoma RiskGlp-1 Receptor Agonists Principles of Medical Therapy for GlaucomaSystemic Medications Affecting IopGlp-1 Receptor Agonists

Discussion

Comments and discussion will appear here in a future update.